Fundraising FoxTaiga Biotechnologies
Aurora, US · Delaware corporation
Find your way into Taiga Biotechnologies
Sign up to see every warm intro you have to Taiga Biotechnologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Taiga Biotechnologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
BC
Brian Curtis TurnerCo-founder
YR
Yosef RefaeliCo-founder
Board
DR
Daniel RitchieBoard director
JK
James KellyBoard director
SK
Stephen K. ErkenBrackBoard director
Reported raises · per SEC filings
Form D private placements$37.7M disclosed across 4 rounds · 2014–2020
▶$14MraisedAug 2022 · 20 investors · BiotechnologyRule 506(b)
▶$14MraisedAug 2022 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David J. RiversExecutive Officer
- Daniel RitchieDirector
- Earl WrightDirector
- Brian C. TurnerDirector
- Stephanie DouglasDirector
- Stephen K. ErkenBrackDirector
- Yosef RefaeliDirector
- Offering amount
- $40M
- Amount sold
- $14M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedJun 2019 · 10 investors · BiotechnologyRule 506(b)
▶$3MraisedJun 2019 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James KellyExecutive Officer
- Daniel RitchieDirector
- Stephen K. ErkenbrackDirector
- Yosef RefaeliExecutive Officer, Director
- Brian C. TurnerExecutive Officer, Director
- Earl L. WrightDirector
- Offering amount
- $13.9M
- Amount sold
- $3M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.7MraisedMar 2018 · 20 investors · BiotechnologyRule 506(b)
▶$8.7MraisedMar 2018 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James KellyDirector
- Brian C. TurnerExecutive Officer, Director
- Earl L. WrightDirector
- Daniel L. RitchieDirector
- Stephen K. ErkenBrackDirector
- Yosef RefaeliDirector, Executive Officer
- Offering amount
- $20M
- Amount sold
- $8.7M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12MraisedJun 2015 · 21 investors · BiotechnologyRule 506(b)
▶$12MraisedJun 2015 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel L. RitchieDirector
- James KellyDirector
- Brian Curtis TurnerExecutive Officer, Director
- Yosef RefaeliExecutive Officer, Director
- Stephen K. ErkenBrackDirector
- Offering amount
- $12M
- Amount sold
- $12M
- First sale
- May 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Taiga Biotechnologies?
- Taiga Biotechnologies was founded by Brian Curtis Turner, Yosef Refaeli.
- How much funding has Taiga Biotechnologies raised?
- Taiga Biotechnologies has disclosed $37.7M raised across 4 rounds.
- Where is Taiga Biotechnologies headquartered?
- Taiga Biotechnologies is headquartered in Aurora, US.